form8k.htm


 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
______________
 
FORM 8-K
______________
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  May 19, 2010
 
 
ASHLAND INC.
(Exact name of registrant as specified in its charter)
 
 
Kentucky
(State or other jurisdiction of incorporation)
 
 

1-32532
 
20-0865835
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
50 E. RiverCenter Boulevard, Covington, Kentucky  41011
(Address of principal executive offices)   (Zip Code)
 
P.O. Box 391, Covington, Kentucky  41012-0391
(Mailing Address)   (Zip Code)

Registrant’s telephone number, including area code (859) 815-3333
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
           
          
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
   
[  ]
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
 
 
 
 
 


 
1
 
 

 
Item 8.01.  Other Events

On May 19, 2010, the Board of Directors of Ashland Inc. (“Ashland”) declared a quarterly cash dividend of 15 cents per share, payable June 15, 2010, to shareholders of record at the close of business on June 2, 2010.  This is increased from the previous quarterly dividend of 7.5 cents per share.
 
2
 
 
 
 SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
ASHLAND INC.
 
(Registrant)




May 19, 2010
/s/ Lamar M. Chambers
 
Lamar M. Chambers
 
Senior Vice President and
 
Chief Financial Officer

 
 
3